BioCentury
ARTICLE | Company News

Horizon Discovery, Boehringer Ingelheim deal

January 21, 2013 8:00 AM UTC

Horizon will use its Discovery Toolbox technology to evaluate cancer compounds from Boehringer against undisclosed targets at the hit-to-lead, lead optimization and preclinical stages. Under the five-...